Observing the effects of Pipeline embolization on intracranial aneurysms
Official title: Pipeline Embolization Device for Intracranial Aneurysm (PEDIA): a Prospective, Multicenter Cohort Focus on Safety, Efficacy, and Haemodynamics
Run by Zhujiang Hospital · NCT06446778 · Data updated 2026-11-12
This study looks at how well the Pipeline device works and its safety for people with brain aneurysms who have had it implanted.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 22 Years to 75 Years |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Zhujiang Hospital Academic / other |
| Locations | 1 site (Guangzhou, Guangdong) |
| Status | Recruiting |
| Started | September 1, 2022 |
| Main results expected | September 1, 2027 |
| Study ends | September 1, 2030 |
| Registry record updated | November 18, 2024 |
| Trial ID | NCT06446778 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 22 to 75 with diagnosed unruptured intracranial aneurysms suitable for Pipeline embolization.
✕Probably not a fit
Patients with contraindications to flow-diversion treatment, other significant vascular lesions, or those who are pregnant or lactating may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study collects clinical, laboratory, and imaging data from patients with intracranial aneurysms who have undergone Pipeline implantation. The aim is to evaluate the safety and efficacy of the Pipeline embolization device, focusing on aneurysmal occlusion status, incidence of in-stent stenosis, and functional prognosis. Additionally, the study assesses hemodynamic changes before and after the stent implantation. The data gathered will help in understanding the outcomes associated with this treatment approach.
Why it matters
Potential benefit: If successful, this study could improve treatment strategies for patients with intracranial aneurysms, potentially leading to better outcomes and reduced complications.
How similar studies have gone: Other studies using flow-diverter devices for treating intracranial aneurysms have shown promising results, indicating that this approach is supported by prior evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: 1. Aged 22 to 75 years old, male or non-pregnant female; 2. UIA was diagnosed by CTA, MRA, or DSA; 3. The size of aneurysms is between 3 to 25mm; 4. Understands the nature of the procedure and provision of written informed consent; 5. Indications for FD implantation with or without adjunctive coiling; 6. Is willing to return to the investigational site for follow-up according to our protocol. Exclusion criteria: 1. With contraindications to flow-diversion treatment or known allergy to cobalt-chromium alloy or contrast medium; 2. Pregnancy or lactation; 3. Coexist with other vascular lesions (coronary artery disease, abdominal aortic aneurysm, severe intracranial artery stenosis, arteriovenous malformation, dural arteriovenous fistula, Moyamoya disease, etc.); 4. Parent vessel with a diameter \<2.0 mm or ≥5.0 mm.; 5. Unwilling to be followed up or likely to have poor treatment compliance; 6. Life expectancy less than 3 years; 7. Inability to receive anti-platelet or anticoagulant medication; 8. Severe neurological deficit that renders the patient unable to live independently (modified Rankin score ≥4); 9. Enrollment in another trial or other situations that the researcher deems unsuitable for inclusion in the study.
Where it's running
-
Zhujiang hospital
Guangzhou, Guangdong, China Recruiting
Study contacts
- Study coordinator: Chuanzhi Duan, MD
- Email: doctor_duanzj@163.com
- Phone: 020-62782757
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Preoperative NPAR and Post-Induction Hemodynamic Vulnerability in Major Oncologic Surgery
This study checks if the preoperative neutrophil percentage-to-albumin ratio (NPAR) can flag who might become hemodynamically unstable after anesthesia induction in adults having major cancer surgery.
-
Pulse palpation vs arterial blood pressure in circulatory shock
This study tests how well feeling for a pulse at typical sites matches the actual arterial blood pressure in adults with circulatory shock or risk of failure.
-
Mindfulness-based breathing before spinal anesthesia for elective cesarean delivery
This trial will test whether a 5-minute mindfulness slow-breathing exercise just before spinal anesthesia can reduce blood pressure drops and anxiety in pregnant women having elective cesarean delivery.
-
Real-world use of WallabyPhenox flow-diversion and stent devices for brain aneurysms and vascular injuries
This registry tracks whether WallabyPhenox flow-diverters, stents, and related implants work well and are safe for people treated for brain aneurysms, dissections, pseudoaneurysms, perforations, or related vascular problems.
-
Electrical stimulation plus isometric exercise to improve blood flow in resistant high blood pressure
This will try whether adding upper‑thoracic electrical stimulation (TENS) and isometric exercise to usual blood pressure medications can lower blood pressure and improve peripheral blood flow in men and women aged 50–60 with resistant hypertension.
-
Predicting fluid responsiveness using PLR, PPV, and LVOT VTI in ICU patients
In critically ill adults on ventilators, researchers test whether measuring LVOT VTI during a passive leg raise can help predict who will respond to fluid therapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.